Found: 39
Select item for more details and to access through your institution.
Dapagliflozin reduces albuminuria over 2 years in patients with type 2 diabetes mellitus and renal impairment.
- Published in:
- 2016
- By:
- Publication type:
- Letter
Improved clearance of iohexol with longer haemodialysis despite similar Kt/V for urea.
- Published in:
- Nephrology Dialysis Transplantation, 1999, v. 14, n. 10, p. 2407, doi. 10.1093/ndt/14.10.2407
- By:
- Publication type:
- Article
Cover Image, Volume 22, Issue 7.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 7, p. 1, doi. 10.1111/dom.14113
- By:
- Publication type:
- Article
Efficacy and safety of dual add‐on therapy with dapagliflozin plus saxagliptin versus glimepiride in patients with poorly controlled type 2 diabetes on a stable dose of metformin: Results from a 52‐week, randomized, active‐controlled trial
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 7, p. 1083, doi. 10.1111/dom.13997
- By:
- Publication type:
- Article
Dapagliflozin plus saxagliptin add‐on to metformin reduces liver fat and adipose tissue volume in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 7, p. 1094, doi. 10.1111/dom.14004
- By:
- Publication type:
- Article
Efficacy and safety of dapagliflozin plus saxagliptin versus insulin glargine over 52 weeks as add‐on to metformin with or without sulphonylurea in patients with type 2 diabetes: A randomized, parallel‐design, open‐label, Phase 3 trial
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 6, p. 957, doi. 10.1111/dom.13981
- By:
- Publication type:
- Article
Triple therapy with low‐dose dapagliflozin plus saxagliptin versus dual therapy with each monocomponent, all added to metformin, in uncontrolled type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 9, p. 2152, doi. 10.1111/dom.13795
- By:
- Publication type:
- Article
Sustained 52‐week efficacy and safety of triple therapy with dapagliflozin plus saxagliptin versus dual therapy with sitagliptin added to metformin in patients with uncontrolled type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 883, doi. 10.1111/dom.13594
- By:
- Publication type:
- Article
Efficacy and safety of dapagliflozin or dapagliflozin plus saxagliptin versus glimepiride as add‐on to metformin in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 11, p. 2598, doi. 10.1111/dom.13437
- By:
- Publication type:
- Article
Safety and tolerability of dapagliflozin, saxagliptin and metformin in combination: <italic>Post‐hoc</italic> analysis of concomitant add‐on versus sequential add‐on to metformin and of triple versus dual therapy with metformin.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1542, doi. 10.1111/dom.13258
- By:
- Publication type:
- Article
Saxagliptin add‐on therapy in Chinese patients with type 2 diabetes inadequately controlled by insulin with or without metformin: Results from the SUPER study, a randomized, double‐blind, placebo‐controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 4, p. 1044, doi. 10.1111/dom.13161
- By:
- Publication type:
- Article
Efficacy and safety of saxagliptin in combination with metformin as initial therapy in Chinese patients with type 2 diabetes: Results from the START study, a multicentre, randomized, double‐blind, active‐controlled, phase 3 trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 590, doi. 10.1111/dom.13117
- By:
- Publication type:
- Article
Metformin extended‐release versus immediate‐release: An international, randomized, double‐blind, head‐to‐head trial in pharmacotherapy‐naïve patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. 463, doi. 10.1111/dom.13104
- By:
- Publication type:
- Article
Dapagliflozin once daily plus exenatide once weekly in obese adults without diabetes: Sustained reductions in body weight, glycaemia and blood pressure over 1 year.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 9, p. 1276, doi. 10.1111/dom.12954
- By:
- Publication type:
- Article
Dapagliflozin once-daily and exenatide once-weekly dual therapy: A 24-week randomized, placebo-controlled, phase II study examining effects on body weight and prediabetes in obese adults without diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 1, p. 49, doi. 10.1111/dom.12779
- By:
- Publication type:
- Article
Hypersensitivity Events, Including Potentially Hypersensitivity-Related Skin Events, with Dapagliflozin in Patients with Type 2 Diabetes Mellitus: A Pooled Analysis.
- Published in:
- Clinical Drug Investigation, 2016, v. 36, n. 11, p. 925, doi. 10.1007/s40261-016-0438-3
- By:
- Publication type:
- Article
A Randomized Controlled Trial of Dapagliflozin Plus Once-Weekly Exenatide Versus Placebo in Individuals with Obesity and Without Diabetes: Metabolic Effects and Markers Associated with Bodyweight Loss.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 4, p. 1511, doi. 10.1007/s13300-018-0449-6
- By:
- Publication type:
- Article
Characterization of the Open-Label Lead-In Period of Two Randomized Controlled Phase 3 Trials Evaluating Dapagliflozin, Saxagliptin, and Metformin in Type 2 Diabetes.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 4, p. 1703, doi. 10.1007/s13300-018-0445-x
- By:
- Publication type:
- Article
Social Integration as Professional Field: Psychotherapy in Sweden.
- Published in:
- Professions & Professionalism, 2013, v. 3, n. 2, p. 1, doi. 10.7577/pp.559
- By:
- Publication type:
- Article
Editorial.
- Published in:
- Professions & Professionalism, 2011, v. 1, n. 1, p. 1, doi. 10.7577/pp.v1i1.140
- By:
- Publication type:
- Article
Effect of the SGLT2 Inhibitor Dapagliflozin on Potassium Levels in Patients with Type 2 Diabetes Mellitus: A Pooled Analysis.
- Published in:
- Diabetes Therapy, 2016, v. 7, n. 1, p. 125, doi. 10.1007/s13300-015-0150-y
- By:
- Publication type:
- Article
Assessing Bladder Cancer Risk in Type 2 Diabetes Clinical Trials: the Dapagliflozin Drug Development Program as a 'Case Study'.
- Published in:
- Diabetes Therapy, 2015, v. 6, n. 3, p. 357, doi. 10.1007/s13300-015-0128-9
- By:
- Publication type:
- Article
Dapagliflozin Added to Verinurad Plus Febuxostat Further Reduces Serum Uric Acid in Hyperuricemia: The QUARTZ Study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Outpatient Treatment with AZD7442 (Tixagevimab/Cilgavimab) Prevented COVID-19 Hospitalizations over 6 Months and Reduced Symptom Progression in the TACKLE Randomized Trial.
- Published in:
- Infectious Diseases & Therapy, 2023, v. 12, n. 9, p. 2269, doi. 10.1007/s40121-023-00861-7
- By:
- Publication type:
- Article
22. Long-Term Safety and Efficacy of Dapagliflozin in Patients with T2DM and Cardiovascular Disease (106-OR).
- Published in:
- Nederlands Tijdschrift voor Diabetologie (NTvD), 2015, v. 13, n. 3, p. 77, doi. 10.1007/s12467-015-0043-8
- By:
- Publication type:
- Article
27. Dapagliflozin Reduces Albuminuria on Top of Renin-Angiotensin System Blockade in Hypertensive Diabetic Patients (1176-P).
- Published in:
- Nederlands Tijdschrift voor Diabetologie (NTvD), 2015, v. 13, n. 3, p. 81, doi. 10.1007/s12467-015-0048-3
- By:
- Publication type:
- Article
Long-Term Safety of Dapagliflozin in Older Patients with Type 2 Diabetes Mellitus: A Pooled Analysis of Phase IIb/III Studies.
- Published in:
- Drugs & Aging, 2016, v. 33, n. 7, p. 511, doi. 10.1007/s40266-016-0382-1
- By:
- Publication type:
- Article
Unrestricted pore area(A[sub0]/Δx) is a better indicator of peritoneal membrane function that PET.
- Published in:
- Kidney International, 2000, v. 58, n. 4, p. 1773, doi. 10.1046/j.1523-1755.2000.00339.x
- By:
- Publication type:
- Article
High glomerular permeability of bikunin despite similarity in charge and hydrodynamic size to serum albumin.
- Published in:
- Kidney International, 1997, v. 51, n. 4, p. 1053, doi. 10.1038/ki.1997.147
- By:
- Publication type:
- Article
Glomerular permselectivity is dependent on adequate serum concentrations of orosomucoid.
- Published in:
- Kidney International, 1992, v. 41, n. 2, p. 310, doi. 10.1111/1523-1755.ep14982030
- By:
- Publication type:
- Article
Dapagliflozin lowers blood pressure in hypertensive and non-hypertensive patients with type 2 diabetes.
- Published in:
- Diabetes & Vascular Disease Research, 2015, v. 12, n. 5, p. 352, doi. 10.1177/1479164115585298
- By:
- Publication type:
- Article
Efficacy and safety of dapagliflozin in addition to insulin therapy in Japanese patients with type 2 diabetes: Results of the interim analysis of 16-week double-blind treatment period.
- Published in:
- Journal of Diabetes Investigation, 2016, v. 7, n. 4, p. 555, doi. 10.1111/jdi.12453
- By:
- Publication type:
- Article
Efficacy and safety of dapagliflozin in Asian patients with type 2 diabetes after metformin failure: A randomized controlled trial.
- Published in:
- Journal of Diabetes, 2016, v. 8, n. 6, p. 796, doi. 10.1111/1753-0407.12357
- By:
- Publication type:
- Article
Glucagon Levels During Short-Term SGLT2 Inhibition Are Largely Regulated by Glucose Changes in Patients With Type 2 Diabetes.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2019, v. 104, n. 1, p. 193, doi. 10.1210/jc.2018-00969
- By:
- Publication type:
- Article
Glucagon Levels During Short-Term SGLT2 Inhibition Are Largely Regulated by Glucose Changes in Patients With Type 2 Diabetes.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Cardiovascular effects of dapagliflozin in patients with type 2 diabetes and different risk categories: a meta-analysis.
- Published in:
- Cardiovascular Diabetology, 2016, v. 15, p. 13, doi. 10.1186/s12933-016-0356-y
- By:
- Publication type:
- Article
Safety and Efficacy of Combined Tixagevimab and Cilgavimab Administered Intramuscularly or Intravenously in Nonhospitalized Patients With COVID-19: 2 Randomized Clinical Trials.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 4, p. e2310039, doi. 10.1001/jamanetworkopen.2023.10039
- By:
- Publication type:
- Article
Young children's beliefs about including others in their play: Social and moral reasoning about inclusion and exclusion.
- Published in:
- Australasian Journal of Early Childhood, 2012, v. 37, n. 3, p. 137, doi. 10.1177/183693911203700318
- By:
- Publication type:
- Article
Dapagliflozin Plus Saxagliptin Add-on Therapy Compared With Insulin in Patients With Type 2 Diabetes Poorly Controlled by Metformin With or Without Sulfonylurea Therapy: A Randomized Clinical Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article